Fmr LLC purchased a new stake in shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN – Free Report) during the 1st quarter, HoldingsChannel reports. The firm purchased 3,163,482 shares of the company’s stock, valued at approximately $69,280,000. Fmr LLC owned 0.48% of Enliven Therapeutics as of its most recent SEC filing. Other hedge funds have also modified […]
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report)’s share price fell 1.8% during mid-day trading on Tuesday after an insider sold shares in the company. The company traded as low as $16.08 and last traded at $16.08. 727 shares changed hands during mid-day trading, a decline of 99% from the average session volume of 140,922 […]